NeoVista Rolls Out Novel Treatment for AMD Using Radiation

November 17, 2009

NeoVista’s Vidion ANV Therapy System has now been used in patients in Europe.

This novel system involves brachytherapy, or radiation, to treat patients with wet macular degeneration. The device delivers a single dose of strontium-90 beta ionizing radiation to the retina.

Neovista is hopeful that this will be a successful alternative to repeated intraocular injections. The Vidion system is anticipating Phase III trials soon.




Jump down to form below to submit your own comments

Comments are closed.